MedTrace Logo

TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors

NCT02466061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2016-06-02

No results posted yet for this study

Summary

This randomized, controlled study evaluates the efficacy of weigh loss interventions in endometrial cancer survivors, using novel technology-based weight loss platforms. This is a multi-site, pilot feasibility study which will provide preliminary data to support a larger NIH funded, mult-center trial.

Conditions

Interventions

BEHAVIORAL

Telemedicine Weight Management plus Wi-Fi Scale (Arm A)

Telephonic weight loss counseling by trained interventionists, with guided digital scale measurements of weight, lean mass, and fat mass. Counseling sessions and digital weight recording occur at regularly scheduled intervals over a six-month intervention period.

BEHAVIORAL

Text for Diet (Text4Diet) Group (Arm B)

Short Message Service (SMS) text messaging in which participants receive 3-5 text messages each day during a six-month intervention period. The text messages provide tips and reminders to encourage healthy eating and weight loss. Participants on this arm also receive a digital scale to track and report weight as prompted once per week through the text program.

BEHAVIORAL

Enhanced Usual Care Group (Arm C)

Participants are provided with handouts based on American Cancer Society guidelines for healthy eating and exercise.

Sponsors & Collaborators

Principal Investigators

  • Kelly Allison, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466061 on ClinicalTrials.gov